Seagen
SGEN
$228.74
Share price
-0.07%
Change (1 day)
68.92%
Change (1 year)
Categories
Seagen (SGEN) - Cash on Hand
Cash on Hand as of September 2023 : $1.23 B
According to Seagen
's latest financial reports the company has $1.23 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Seagen - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $1.73 B | -19.67% |
| 2021-12-31 | $2.16 B | -18.8% |
| 2020-12-31 | $2.66 B | 206.36% |
| 2019-12-31 | $0.86 B | 88.82% |
| 2018-12-31 | $0.45 B | 11.3% |
| 2017-12-31 | $0.41 B | -33.25% |
| 2016-12-31 | $0.61 B | -13.15% |
| 2015-12-31 | $0.71 B | 127.4% |
| 2014-12-31 | $0.31 B | -16.26% |
| 2013-12-31 | $0.37 B | 2.75% |
| 2012-12-31 | $0.36 B | 10.15% |
| 2011-12-31 | $0.33 B | 17.35% |
| 2010-12-31 | $0.28 B | 8.05% |
| 2009-12-31 | $0.26 B | 174.02% |
| 2008-12-31 | $95.17 M | -14.53% |
| 2007-12-31 | $0.11 B | 34.84% |
| 2006-12-31 | $82.58 M | 94.46% |
| 2005-12-31 | $42.47 M | 14.36% |
| 2004-12-31 | $37.13 M | -9.04% |
| 2003-12-31 | $40.83 M | 54.78% |
| 2002-12-31 | $26.37 M | -37.07% |
| 2001-12-31 | $41.91 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $12.69 B | 925.88% | 🇺🇸 USA |
 AbbVie ABBV | $12.81 B | 936.06% | 🇺🇸 USA |
 Biogen BIIB | $1.04 B | -15.12% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $12.28 B | 892.73% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.35 B | 413.73% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | $56.13 M | -95.46% | 🇺🇸 USA |
 ImmunoGen
IMGN | $0.60 B | -51.05% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.42 B | -65.76% | 🇺🇸 USA |